Relation between axial length of the eye and hypotensive effect of latanoprost in primary open angle glaucoma [PDF]
, 2004 Esther Arranz-Márquez
openalex +1 more source
Latanoprostene bunod: the first nitric oxide-donating antiglaucoma medication. [PDF]
Med Gas ResSoltani G, Shalaby WS, Razeghinejad R.
europepmc +1 more source
A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma [PDF]
, 2005 Madhu Nagar +4 more
openalex +1 more source
Drug-related macular edema: a real-world FDA Adverse Event Reporting System database study. [PDF]
BMC Pharmacol ToxicolLi X +6 more
europepmc +1 more source
PAE11 ECONOMIC EVALUATION OF LATANOPROST AS FIRST LINE GLAUCOMA THERAPY IN 6 EUROPEAN COUNTRIES
, 2003 Samuel Aballéa +3 more
openalex +1 more source
Lack of efficacy of topical latanoprost in the treatment of eyebrow alopecia areata [PDF]
, 2005 Elizabeth K. Ross +3 more
openalex +1 more source
Association of Matrix Metalloproteinases Polymorphisms with Glaucoma Risk, Glaucoma Phenotype, and Response to Treatment with Selective Laser Trabeculoplasty or Latanoprost. [PDF]
Int J Mol SciAtanasovska Velkovska M +4 more
europepmc +1 more source
Effects of Brimonidine, Latanoprost, and Omidenepag on Tunicamycin-Induced Endoplasmic Reticulum Stress and Fibrosis in Human Trabecular Meshwork Cells. [PDF]
BiomoleculesLiu M, Honjo M, Yamagishi R, Aihara M.
europepmc +1 more source
Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost in patients with primary open angle glaucoma or ocular hypertension [PDF]
, 2006 Toshinori Chiba
openalex +1 more source